| DPAM B EQUITIES DRAGONS SUSTAINABLE W USD CAP | RVI ASIA PACÍFICO | 49,32% | 52,06% | 10,78% | · |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 49,32% | 20,05% | -32,59% | · |
| ROBECO EMERGING MARKETS EQUITIES F USD | RVI EMERGENTES | 49,32% | 79,32% | 61,41% | 184,06% |
| BGF EMERGING MARKETS A4 EUR | RVI EMERGENTES | 49,31% | 51,04% | 11,44% | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) EUR | RVI BIOTECNOLOGÍA | 49,31% | 25,54% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EQUITY ESG PORTFOLIO E EUR CAP | RVI EMERGENTES | 49,31% | 71,96% | 21,51% | · |
| AMUNDI FUNDS EMERGING MARKETS EQUITY GROWTH OPPORTUNITIES R USD (C) | RVI EMERGENTES | 49,30% | 84,77% | 53,96% | · |
| BGF EMERGING MARKETS I4 EUR | RVI EMERGENTES | 49,30% | 51,27% | · | · |
| T.ROWE ASIAN EX-JAPAN EQUITY FUND Q | RVI ASIA EX-JAPÓN | 49,30% | 61,10% | 26,36% | 140,10% |
| JPM CHINA A-SHARE OPPORTUNITIES C (DIST) GBP | RVI CHINA | 49,28% | 28,63% | -17,39% | · |
